Latka logo

Dokin vs MediFusion: Revenue, Funding & Team Size Compared

Dokin generates $330K in revenue; MediFusion generates $330K. Dokin and MediFusion are close to the same size by revenue. The table below compares Dokin and MediFusion on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

Dokin vs MediFusion compared on revenue, funding, valuation, customers and team size
CompanyDokin logoDokinThis companyMediFusion logoMediFusion
Revenue$330K$330K
Team size33
HQParis, FranceSeattle, United States

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

Dokin logo

Dokin at a glance

Dokin generates $330K in revenue with 3 employees, headquartered in Paris, France.

Revenue
$330K
Team size
3

The data platform of modern business teams. Dokin is a no-code solution that allows business teams to automate the process of syncing live data from external software to Google Workspace applications. With customizable templates and…

MediFusion logo

MediFusion at a glance

MediFusion generates $330K in revenue with 3 employees, headquartered in Seattle, United States.

Revenue
$330K
Team size
3

As a leading solution for electronic health records (EHR) and practice management (PM) requirements in the healthcare industry, MediFusion provides a mature time-tested platform with cutting edge tech to medical providers, practices, and…

Other Dokin alternatives

Dokin competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

Dokin vs MediFusion: frequently asked questions

Is Dokin or MediFusion bigger?

Dokin is the bigger company by revenue, at $330K against $330K for MediFusion.

How much revenue does Dokin make?

Dokin generates $330K in annual revenue with a team of 3.

How much revenue does MediFusion make?

MediFusion generates $330K in annual revenue with a team of 3.